DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 1Dr.Reddy's Laboratories Limited
02 1Dr.Reddy's laboratories Limited
03 1Asclemed USA Inc.
04 1Aurobindo Pharma Limited
05 2Divi's Laboratories Limited
06 1HETERO LABS LIMITED
07 1Medisca Inc.
08 1Professional Compounding Centers of America dba PCCA
09 1Spectrum Laboratory Products, Inc.
10 1Xenex Laboratories Inc
11 1Zhejiang Charioteer Pharmaceutical Co., Ltd.
01 2NAPROXEN
02 1NAPROXEN BASE
03 9Naproxen
01 1Canada
02 1China
03 6India
04 3U.S.A
05 1United Kingdom
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 30007-828
Start Marketing Date : 2010-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
NDC Package Code : 55111-003
Start Marketing Date : 1997-01-28
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65862-958
Start Marketing Date : 2024-01-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63310-2080
Start Marketing Date : 2007-03-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62331-029
Start Marketing Date : 2006-08-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 62331-001
Start Marketing Date : 1999-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 68554-0143
Start Marketing Date : 1994-10-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 38779-0548
Start Marketing Date : 2014-07-11
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 51927-2715
Start Marketing Date : 2013-06-27
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 49452-4815
Start Marketing Date : 1996-04-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1g/g)
Marketing Category : BULK INGREDIENT
A Naproxen manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Naproxen, including repackagers and relabelers. The FDA regulates Naproxen manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Naproxen API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Naproxen manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Naproxen supplier is an individual or a company that provides Naproxen active pharmaceutical ingredient (API) or Naproxen finished formulations upon request. The Naproxen suppliers may include Naproxen API manufacturers, exporters, distributors and traders.
click here to find a list of Naproxen suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Naproxen as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Naproxen API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Naproxen as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Naproxen and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Naproxen NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Naproxen suppliers with NDC on PharmaCompass.
We have 10 companies offering Naproxen
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
